⌘K

Login Start Free

Home/Filings/4/0001127602-13-032659

4//SEC Filing

ARIAD PHARMACEUTICALS INC 4

Accession 0001127602-13-032659

CIK 0000884731operating

View on SEC.gov Company Profile

Filed

Nov 21, 7:00 PM ET

Accepted

Nov 22, 4:36 PM ET

Size

21.4 KB

Accession

0001127602-13-032659

Insider Transaction Report

Form 4

Period: 2013-11-22

ARIAD PHARMACEUTICALS INCARIA

DODION PIERRE F

Senior VP, Chief Medical Off

Transactions

Exercise/Conversion
Common Stock
2013-11-22+9,000→ 82,282 total
Exercise/Conversion
Common Stock
2013-11-22+6,000→ 88,282 total
Exercise/Conversion
Restricted Stock Units
2013-11-22−6,000→ 6,000 total
Exp: 2022-03-20→ Common Stock (6,000 underlying)
Exercise/Conversion
Performance stock unit
2013-11-22−9,000→ 0 total
Exp: 2021-04-01→ Common Stock (9,000 underlying)
Exercise/Conversion
Common Stock
2013-11-22+6,000→ 73,282 total
Exercise/Conversion
Common Stock
2013-11-22+6,250→ 102,532 total
Exercise/Conversion
Restricted Stock Units
2013-11-22−6,250→ 12,500 total
Exp: 2023-03-19→ Common Stock (6,250 underlying)
Exercise/Conversion
Common Stock
2013-11-22+8,000→ 96,282 total
Exercise/Conversion
Restricted Stock Units
2013-11-22−6,000→ 0 total
Exp: 2021-04-01→ Common Stock (6,000 underlying)
Exercise/Conversion
Performance stock unit
2013-11-22−8,000→ 8,000 total
Exp: 2022-03-20→ Common Stock (8,000 underlying)

Holdings

Common Stock
(indirect: By Spouse)
0

Footnotes (2)

[F1]Each restricted stock unit or performance stock unit represents a right to receive one share of ARIAD common stock.
[F2]The vesting of these awards were accelerated to November 22, 2013, the reporting person's last day of employment with the Company, under the terms of his employment agreement.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

ARIAD PHARMACEUTICALS INC

CIK 0000884731

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000884731

Filing Metadata

Form type: 4
Filed: Nov 21, 7:00 PM ET
Accepted: Nov 22, 4:36 PM ET
Size: 21.4 KB

View on SEC.gov